En Es
Categories

Luminex Corporation

Luminex Corporation

Luminex develops, manufactures, and markets biological testing technologies with applications in clinical diagnostics, pharmaceutical drug discovery, biomedical research, including genomic and proteomic research, personalized medicine, biodefense research, and food safety. The company’s open-architecture xMAP technolog ...
Products Covid-19NewsSummary
Close

Covid-19 Luminex Corporation

Clinical Laboratory

Respiratory Assay
VERIGENE ll Respiratory Flex Assay

The VERIGENE ll Respiratory Flex Assay is a sample-to-answer test that detects 14 viral pathogens, including SARS-CoV-2, and five bacterial pathogens. Using the VERIGENE ll System, extraction, PCR, and detection all take place in a self-contained cassette. The VERIGENE II Respiratory Flex Assay is designed for flexible, comprehensive detection of common respiratory pathogens.
More details

Respiratory Pathogen Panel + SARS-CoV-2
NxTAG Respiratory Pathogen Panel + SARS-CoV-2

The NxTAG Respiratory Pathogen Panel + SARS-CoV-2 (NxTAG RPP + SARS‑CoV‑2), developed for use on the NxTAG-Enabled MAGPIX® System, is a qualitative test for the detection of nucleic acids from multiple respiratory viruses and bacteria in nasopharyngeal swabs. The formulation of the assay is identical to NxTAG RPP, with the exception of the additional reagents required for the detection of SARS‑CoV‑2. No changes have been made to the existing NxTAG RPP reagents, reaction conditions, workflow, or software thresholds; therefore, the performance characteristics of NxTAG RPP are still applicable to NxTAG RPP + SARS‑CoV‑2.
More details

SARS-CoV-2 Test
NxTAG CoV Extended Panel

The NxTAG CoV Extended Panel offers SARS-CoV-2 detection using three viral genes (ORF1ab, E gene, and N gene), enabling accurate, reliable results. It is a highly scalable, cost-effective solution that can process up to 96 samples in approximately four hours and was developed for use on the MAGPIX NxTAG-enabled System. It has received Emergency Use Authorization (EUA) from the US FDA and Medical Device Authorization for Importation or Sale for Health Canada.
More details

SARS-CoV-2 Test
ARIES SARS-CoV-2 Assay

The ARIES SARS-CoV-2 Assay is a moderate-complexity, sample-to-answer test that detects SARS-CoV-2 in nasopharyngeal swabs. It allows for minimal hands-on time and an automated workflow deliver results in about two hours. Additionally, exonuclease-sensitive probes for the ORF1ab and N viral genes provide superior specificity.
More details

SARS-CoV2 Antibody Test
xMAP SARS-CoV-2 Multi-Antigen IgG Assay

The xMAP SARS-CoV-2 Multi-Antigen IgG Assay is a multiplex, microsphere-based, highly sensitive and specific assay that detects the presence or absence of antibodies against three different SARS-CoV-2 antigens. By using a combination of robust internal controls and highly-specific antigens, the assay may provide earlier, more sensitive results.
More details
Close

News of Luminex Corporation

DiaSorin Completes Acquisition of Luminex to Become a Full-Fledged Diagnostic and Life Science Player

16 Jul 2021
DiaSorin Completes Acquisition of Luminex to Become a Full-Fledged Diagnostic and Life Science Player
DiaSorin S.p.A. (?Saluggia?, Italy) has completed the acquisition of Luminex Corporation (Austin, TX, USA), allowing it to gain access to Luminex’s multiplexing technology and a portfolio that will strengthen its existing offering, while expanding the Group presence in the US.
Read More

DiaSorin to Acquire Luminex to Broaden Positioning in Molecular Diagnostics Space

13 Apr 2021
DiaSorin to Acquire Luminex to Broaden Positioning in Molecular Diagnostics Space
DiaSorin S.p.A. (?Saluggia?, Italy) has announced that its Board of Directors has unanimously approved and signed a definitive merger agreement for DiaSorin to acquire Luminex Corporation (Austin, TX, USA) for approximately USD 1.8 billion.
Read More
Close

About Luminex Corporation

Luminex develops, manufactures, and markets biological testing technologies with applications in clinical diagnostics, pharmaceutical drug discovery, biomedical research, including genomic and proteomic research, personalized medicine, biodefense research, and food safety. The company’s open-architecture xMAP technology enables large numbers of biological tests (bioassays) to be conducted and analyzed quickly, cost-effectively and accurately.

Recently updated

Molecular Diagnostic Platform
VERIGENE II System

The VERIGENE II System is a sample-to-answer molecular diagnostic platform capable of performing both targeted and multiplex testing on a single sample. The system is fully-integrated and performs extraction, amplification, hybridization, and detection—all in one cartridge. Its proprietary Flex Software enables users to test and pay only for the targets ordered by the clinician, with the option to unmask additional results as needed. This unique capability provides laboratories and clinicians with a cost-effective diagnostic tool that is designed to improve clinical outcomes.
More details

Respiratory Assay
VERIGENE ll Respiratory Flex Assay

The VERIGENE ll Respiratory Flex Assay is a sample-to-answer test that detects 14 viral pathogens, including SARS-CoV-2, and five bacterial pathogens. Using the VERIGENE ll System, extraction, PCR, and detection all take place in a self-contained cassette. The VERIGENE II Respiratory Flex Assay is designed for flexible, comprehensive detection of common respiratory pathogens.
More details

Gastrointestinal Assay
VERIGENE II Gastrointestinal Flex Assay

The VERIGENE II Gastrointestinal Flex Assay is a sample-to-answer test that detects 24 GI targets - including bacteria, viruses, and parasites - associated with gastroenteritis. Using the VERIGENE ll System, extraction, PCR, and detection all take place in a self-contained cassette. The new assay is designed for simple, fast, and flexible detection of infectious GI pathogens.
More details

Clinical Laboratory

Molecular Diagnostic Platform
VERIGENE II System

The VERIGENE II System is a sample-to-answer molecular diagnostic platform capable of performing both targeted and multiplex testing on a single sample. The system is fully-integrated and performs extraction, amplification, hybridization, and detection—all in one cartridge. Its proprietary Flex Software enables users to test and pay only for the targets ordered by the clinician, with the option to unmask additional results as needed. This unique capability provides laboratories and clinicians with a cost-effective diagnostic tool that is designed to improve clinical outcomes.
More details

Respiratory Assay
VERIGENE ll Respiratory Flex Assay

The VERIGENE ll Respiratory Flex Assay is a sample-to-answer test that detects 14 viral pathogens, including SARS-CoV-2, and five bacterial pathogens. Using the VERIGENE ll System, extraction, PCR, and detection all take place in a self-contained cassette. The VERIGENE II Respiratory Flex Assay is designed for flexible, comprehensive detection of common respiratory pathogens.
More details

Gastrointestinal Assay
VERIGENE II Gastrointestinal Flex Assay

The VERIGENE II Gastrointestinal Flex Assay is a sample-to-answer test that detects 24 GI targets - including bacteria, viruses, and parasites - associated with gastroenteritis. Using the VERIGENE ll System, extraction, PCR, and detection all take place in a self-contained cassette. The new assay is designed for simple, fast, and flexible detection of infectious GI pathogens.
More details

Methicillin-Resistant Staphylococcus Aureus (MRSA) Assay
ARIES MRSA Assay

The ARIES MRSA Assay aids in the prevention and control of Methicillin-resistant Staphylococcus aureus (MRSA), a Gram-positive bacteria that is resistant to several antibiotics, infections in healthcare settings. To increase the confidence in a MRSA call, the ARIES MRSA Assay includes mecA/mecC resistance gene detection, and SCCmec and orfX targets to ensure the resistance gene is associated with and present in S. aureus.
More details

Flow Cytometer
Amnis CellStream

The Amnis CellStream benchtop flow cytometry systems are highly-customizable, compact flow cytometers that use patented time delay integration charge-coupled device (TDI CCD) camera technology for detection, offering exceptional sensitivity for studying small particles. Combined with intuitive software and high-throughput acquisition, the systems allow users to resolve complex cell populations and view cells as they are analyzed in real time—making quality control and obtaining consistent results easier than ever.
More details

Cell Analyzer
Guava Muse Cell Analyzer

The Guava Muse Cell Analyzer packs 3-parameter analysis into a compact, easy to use benchtop device, making flow cytometry accessible to anyone, anytime. The Muse Instrument has an integrated touchscreen and software for data acquisition and analysis using optimized Muse Assays. Its microcapillary flow cell is engineered for acquisition of both suspension and adherent cells 2-60 microns in diameter.
More details

Respiratory Pathogen Panel + SARS-CoV-2
NxTAG Respiratory Pathogen Panel + SARS-CoV-2

The NxTAG Respiratory Pathogen Panel + SARS-CoV-2 (NxTAG RPP + SARS‑CoV‑2), developed for use on the NxTAG-Enabled MAGPIX® System, is a qualitative test for the detection of nucleic acids from multiple respiratory viruses and bacteria in nasopharyngeal swabs. The formulation of the assay is identical to NxTAG RPP, with the exception of the additional reagents required for the detection of SARS‑CoV‑2. No changes have been made to the existing NxTAG RPP reagents, reaction conditions, workflow, or software thresholds; therefore, the performance characteristics of NxTAG RPP are still applicable to NxTAG RPP + SARS‑CoV‑2.
More details

SARS-CoV2 Antibody Test
xMAP SARS-CoV-2 Multi-Antigen IgG Assay

The xMAP SARS-CoV-2 Multi-Antigen IgG Assay is a multiplex, microsphere-based, highly sensitive and specific assay that detects the presence or absence of antibodies against three different SARS-CoV-2 antigens. By using a combination of robust internal controls and highly-specific antigens, the assay may provide earlier, more sensitive results.
More details

SARS-CoV-2 Test
ARIES SARS-CoV-2 Assay

The ARIES SARS-CoV-2 Assay is a moderate-complexity, sample-to-answer test that detects SARS-CoV-2 in nasopharyngeal swabs. It allows for minimal hands-on time and an automated workflow deliver results in about two hours. Additionally, exonuclease-sensitive probes for the ORF1ab and N viral genes provide superior specificity.
More details

SARS-CoV-2 Test
NxTAG CoV Extended Panel

The NxTAG CoV Extended Panel offers SARS-CoV-2 detection using three viral genes (ORF1ab, E gene, and N gene), enabling accurate, reliable results. It is a highly scalable, cost-effective solution that can process up to 96 samples in approximately four hours and was developed for use on the MAGPIX NxTAG-enabled System. It has received Emergency Use Authorization (EUA) from the US FDA and Medical Device Authorization for Importation or Sale for Health Canada.
More details

BC-GN Test
VERIGENE BC-GN Test

The VERIGENE BC-GN Test identifies genus, species, and genetic resistance determinants for a broad panel of gram-negative bacteria directly from positive blood culture bottles. It provides results within two hours of blood culture positivity, reducing time to patient therapy and increasing cost savings.
More details

BC-GP Test
VERIGENE BC-GP Test

The VERIGENE BC-GP Test identifies genus, species, and genetic resistance determinants for a broad panel of gram-positive bacteria directly from positive blood culture bottles. It provides results within 2.5 hours of blood culture positivity, reducing time to patient therapy and increasing cost savings.
More details

Molecular Diagnostics Workstation
VERIGENE System

The VERIGENE System is a workstation for molecular diagnostics that utilizes advanced automation and proprietary chemistry to enable rapid, sample to result detection of nucleic acid and protein targets. It offers automated, cost-effective multiplex capabilities that rapidly and accurately detect infectious pathogens and drug resistance markers, without relying on time-consuming culture methods.
More details

Multiplex Reader
Luminex 200

The Luminex 200 multiplex reader is a clinical diagnostics instrument that allows multiplexing of up to 100 analytes in a single well of a microtiter plate, using very small samples. It delivers fast and cost-effective bioassay results on many assay formats including nucleic acid assays, receptor-ligand assays, immunoassays, and enzymatic assays.
More details

Multiplex Reader
MAGPIX

The MAGPIX is a compact multiplex reader that can perform up to 50 different tests in a single reaction volume and read a 96-well-plate in 60 minutes. It features self-cleaning routines and magnetic bead compatibility, making the instrument easy to learn and easy to use.
More details

Rapid Immunoassay Test
ARIES Flu A/B & RSV

The ARIES Flu A/B & RSV assay is for the detection/differentiation of influenza A&B, and RSV from nasopharyngeal swabs. It features integrated sample processing control to ensure the assay run is successful from extraction through amplification with results delivered in less than two hours.
More details

Flow Cytometry Analyzer
Luminex 200

The Luminex 200 is a flow cytometry analyzer which allows for simultaneously measurement of up to 100 analytes in a single microplate well, using very small samples, and includes an analyzer, plate handling platform, sheath fluid delivery system, software, and PC. It delivers fast and cost-effective bioassay results on many assay formats, including nucleic acid assays, receptor-ligand assays, immunoassays, and enzymatic assays.
More details

Immunoassay System
FLEXMAP 3D

The FLEXMAP 3D is a multiplexing platform with fast read time, compatibility with both 96- and 384-well plates, and ease of integration with front-end automation systems. It uses both magnetic and non-magnetic microspheres and can simultaneously measure up to 500 genes or proteins from a small sample, making it ideal for high throughput applications.
More details

In Vitro Diagnostic System
ARIES M1

The ARIES M1 is a fully integrated, sample to answer platform for performing real-time PCR assays with features such as an intuitive system interface, STAT or batch testing, and true walkaway capability. It extracts, amplifies and detects nucleic acid targets from a variety of sample types, and can process up to six different samples, and one to six assays, at a time, making it ideal for lower throughput clinical labs.
More details
Copyright © 2000-2022 TradeMed.com. All rights reserved. | Terms And Conditions